Two Biotech Stocks Considered Potential Buyout Targets
The pharmaceutical sector has seen a surge in mergers and acquisitions, with over $65 billion in deals reported by PwC for the first quarter of this year. Two biotech stocks highlighted as potential takeover targets are Legend Biotech (LEGN) and BioNTech (BNTX). Both companies have shown strong commercial or clinical progress that could make them attractive to larger pharmaceutical firms.
Tickers: $ABBV $BNTX $JNJ $LEGN
Topics: biotech mergers and acquisitions pharma